In rabbits prone to atherosclerosis, one compound reduced plaque deposits by 30% in three months.

FORBES: On The Cover/Top Stories

One explanation is that the patients in ENHANCE had been better treated and had less atherosclerosis, making it harder to prevent plaque buildup.

FORBES: Vytorin On Trial